Test Price
2,800 AEDโ Home Collection Available
G6PD Deficiency (Favism) Susceptibility Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Executive Summary
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
Clinical Guidance: Telephonic PostโTest Clinical Guidance in result interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The G6PD Susceptibility Genetic Test analyzes the G6PD gene for variants associated with favism, a genetic enzyme deficiency that can cause hemolytic anemia upon exposure to certain triggers. This NGSโbased test provides comprehensive screening and is essential for individuals with a family history or suspicious symptoms. Unlike standard enzyme activity assays, this molecular test identifies both carriers and affected individuals with high precision.
| Feature | Our G6PD NGS Test | Standard Enzyme Activity Test |
|---|---|---|
| Method | Next Generation Sequencing (NGS) | Spectrophotometric Enzyme Assay |
| Precision | >99.9% analytical sensitivity for all known pathogenic variants | Cannot differentiate variant type; may miss low-level enzyme activity |
| Carrier Status Detection | Yes, identifies heterozygous carriers | No, only quantifies current enzyme level |
| Turnaround Time | 3โ4 Weeks | 1โ2 Days |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403
โAs a clinical geneticist, I see that a possible diagnosis of favism can be concerning for patients and families. This genetic test is a powerful tool to identify susceptibility, but results must be interpreted alongside a full pedigree and clinical history. I strongly recommend post-test genetic counseling to understand risk stratification and preventive management.โ
Advisory: Medication Precautions
Do not discontinue or alter prescribed medications without consulting your physician. Certain drugs can trigger hemolysis in G6PD-deficient individuals; your doctor can provide a safe medication list.
Exclusion Criteria & Emergency Red Flags
- Testing is not advised during an acute hemolytic crisis. If you are currently experiencing dark urine, jaundice, or shortness of breath, seek emergency care immediately.
- Pediatric testing requires valid parental or guardian consent.
- Pregnant women should inform their physician before testing; results may influence perinatal management.
- ER Red Flags: Sudden onset of pale skin, rapid heartbeat, confusion, or blood in urine after eating fava beans or taking sulfa drugs, aspirin, or nitrofurantoin requires immediate medical attention.
Patient FAQ & Clinical Guidance
1. What is the G6PD Favism Susceptibility Test?
This is a genetic test using Next Generation Sequencing to screen for all known pathogenic variants in the G6PD gene. It reliably identifies both carriers and affected individuals, enabling personalized preventive measures to avoid hemolytic triggers.
2. How should I prepare for the G6PD genetic test?
No fasting or special preparation is required. However, a mandatory pre-test genetic counselling session is needed to document your family history and obtain informed consent. You may be asked to provide a detailed clinical history to aid result interpretation.
3. What do the results mean?
A positive result indicates you carry a G6PD gene mutation, increasing your risk of favism. You should avoid fava beans, certain medications, and other triggers. A negative result greatly reduces this risk but does not eliminate all enzyme deficiencies. Always discuss your report with a physician to create a safe management plan.
UAE Regulatory & Data Privacy Adherence
Data Protection & Health Information Governance
- All genetic data is handled in strict compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).
- Health information management follows Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Clinical safety and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
- DHA Facility License: 1143 | Laboratory Address: Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE.
Clinical & Logistical Metadata
| Test Name | G6PD Deficiency (Favism) Susceptibility Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Whole Blood (peripheral), Extracted DNA, or Dried Blood Spot (FTA Card) |
| Methodology Used | Next Generation Sequencing (NGS) |
| ICD-10-CM Code | D55.0 |
| LOINC Code | 82794-6 |
| DHA Facility License & Laboratory Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians